Current and Promising Antivirals Against Chikungunya Virus

被引：29
|
作者：
Hucke, Friederike I. L. [1 ]
Bugert, Joachim J. [1 ]
机构：
[1] Bundeswehr Inst Microbiol, Dept Virol, Munich, Germany
来源：
FRONTIERS IN PUBLIC HEALTH | 2020年 / 8卷
关键词：
antiviral design; CHIKV therapy; direct antiviral action; host-targeting antiviral; comparison of in vitro efficacies; favipiravir; ribavirin; PROTEIN-KINASE-C; SMALL-MOLECULE INHIBITORS; STRAND RNA VIRUSES; MYCOPHENOLIC-ACID; IN-VITRO; EQUINE ENCEPHALITIS; NATURAL-PRODUCTS; POTENT INHIBITOR; PHORBOL ESTERS; SINDBIS VIRUS;
D O I：
10.3389/fpubh.2020.618624
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Chikungunya virus (CHIKV) is the causative agent of chikungunya fever (CHIKF) and is categorized as a(n) (re)emerging arbovirus. CHIKV has repeatedly been responsible for outbreaks that caused serious economic and public health problems in the affected countries. To date, no vaccine or specific antiviral therapies are available. This review gives a summary on current antivirals that have been investigated as potential therapeutics against CHIKF. The mode of action as well as possible compound targets (viral and host targets) are being addressed. This review hopes to provide critical information on the in vitro efficacies of various compounds and might help researchers in their considerations for future experiments.
引用
收藏
页数：23
相关论文
共 50 条
  • [1] Antivirals against the Chikungunya Virus
    Battisti, Verena
    Urban, Ernst
    Langer, Thierry
    VIRUSES-BASEL, 2021, 13 (07):
  • [2] Towards antivirals against chikungunya virus
    Abdelnabi, Rana
    Neyts, Johan
    Delang, Leen
    ANTIVIRAL RESEARCH, 2015, 121 : 59 - 68
  • [3] Antivirals Against Chikungunya Virus: Is the Solution in Nature?
    Silva Martins, Daniel Oliveira
    Santos, Igor de Andrade
    de Oliveira, Debora Moraes
    Grosche, Victoria Riquena
    Gomes Jardim, Ana Carolina
    VIRUSES-BASEL, 2020, 12 (03):
  • [4] Viral methyltransferase inhibitors: berbamine, venetoclax, and ponatinib as efficacious antivirals against chikungunya virus
    Bhutkar, Mandar
    Saha, Ankita
    Tomar, Shailly
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2024, 759
  • [5] Intranasal antivirals against respiratory syncytial virus: the current therapeutic development landscape
    Oti, Victor Baba
    Idris, Adi
    McMillan, Nigel A. J.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024, 22 (08) : 647 - 657
  • [6] Novel α-mangostin derivatives as promising antiviral agents: Isolation, synthesis, and evaluation against chikungunya virus
    Priya, Telukuntla Sai
    Patil, Poonam
    Siva, Bandi
    Roy, Diya
    Dhote, Radhika
    Parashar, Deepti
    Alagarasu, Kalichamy
    Cherian, Sarah
    Babu, K. Suresh
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 284
  • [7] Nitrogen-Based Heterocyclic Compounds: A Promising Class of Antiviral Agents against Chikungunya Virus
    Santana, Andreza C.
    Silva Filho, Ronaldo C.
    Menezes, Jose C. J. M. D. S.
    Allonso, Diego
    Campos, Vinicius R.
    LIFE-BASEL, 2021, 11 (01): : 1 - 15
  • [8] Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses
    Varghese, Finny S.
    Kaukinen, Pasi
    Glaesker, Sabine
    Bespalov, Maxim
    Hanski, Leena
    Wennerberg, Krister
    Kuemmerer, Beate M.
    Ahola, Tero
    ANTIVIRAL RESEARCH, 2016, 126 : 117 - 124
  • [9] Chikungunya Virus: Current Perspectives on a Reemerging Virus
    Morrison, Clayton R.
    Plante, Kenneth S.
    Heise, Mark T.
    MICROBIOLOGY SPECTRUM, 2016, 4 (03):
  • [10] Introduction to the antivirals against Dengue virus
    Carocci, Margot
    VIROLOGIE, 2020, 24 (04) : 231 - 245
12345